Israel Englander Surmodics Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Surmodics Inc stock. As of the latest transaction made, Millennium Management LLC holds 119,835 shares of SRDX stock, worth $4.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

119,835

Previous 76,997 55.64%

Holding current value

$4.56 Million

Previous $3.24 Million 43.6%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$38.47 - $42.24 $1.65 Million - $1.81 Million	42,838 Added 55.64%	119,835 $4.65 Million
Q2 2024 Aug 14, 2024	SELL	$25.39 - $42.1 $12.8 Million - $21.3 Million	-506,030 Reduced 86.79%	76,997 $3.24 Million
Q1 2024 May 15, 2024	SELL	$27.44 - $35.56 $2.43 Million - $3.15 Million	-88,524 Reduced 13.18%	583,027 $17.1 Million
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $9.79 Million - $13.2 Million	-343,697 Reduced 33.85%	671,551 $24.4 Million
Q2 2023 Aug 14, 2023	BUY	$17.67 - $31.31 $317,105 - $561,889	17,946 Added 1.8%	1,015,248 $31.8 Million
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $12.3 Million - $27.6 Million	717,599 Added 256.56%	997,302 $22.7 Million
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $1.29 Million - $1.64 Million	43,901 Added 18.62%	279,703 $9.54 Million
Q3 2022 Nov 14, 2022	BUY	$28.84 - $38.92 $1.26 Million - $1.7 Million	43,629 Added 22.7%	235,802 $7.17 Million
Q2 2022 Aug 15, 2022	SELL	$33.25 - $45.11 $5,153 - $6,992	-155 Reduced 0.08%	192,173 $7.16 Million
Q1 2022 May 16, 2022	BUY	$40.68 - $49.72 $5.31 Million - $6.49 Million	130,494 Added 211.04%	192,328 $8.72 Million
Q4 2021 Feb 14, 2022	SELL	$43.21 - $57.6 $463,081 - $617,299	-10,717 Reduced 14.77%	61,834 $2.98 Million
Q3 2021 Nov 15, 2021	SELL	$52.8 - $60.32 $1.84 Million - $2.1 Million	-34,870 Reduced 32.46%	72,551 $4.03 Million
Q2 2021 Aug 16, 2021	BUY	$51.29 - $59.15 $2.92 Million - $3.37 Million	56,977 Added 112.95%	107,421 $5.83 Million
Q1 2021 May 17, 2021	BUY	$42.18 - $56.07 $1.52 Million - $2.02 Million	35,977 Added 248.68%	50,444 $2.83 Million
Q4 2020 Feb 16, 2021	BUY	$35.18 - $43.52 $508,949 - $629,603	14,467 New	14,467 $630,000
Q2 2020 Aug 14, 2020	SELL	$31.07 - $44.74 $5.13 Million - $7.39 Million	-165,146 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$22.46 - $42.24 $918,209 - $1.73 Million	40,882 Added 32.9%	165,146 $5.5 Million
Q4 2019 Feb 14, 2020	BUY	$39.01 - $47.51 $1.43 Million - $1.74 Million	36,575 Added 41.71%	124,264 $5.15 Million
Q3 2019 Nov 14, 2019	SELL	$38.66 - $47.41 $554,577 - $680,096	-14,345 Reduced 14.06%	87,689 $4.01 Million
Q2 2019 Aug 15, 2019	SELL	$38.23 - $47.43 $8.91 Million - $11.1 Million	-233,118 Reduced 69.56%	102,034 $4.41 Million
Q2 2019 Aug 14, 2019	BUY	$38.23 - $47.43 $9.45 Million - $11.7 Million	247,203 Added 281.08%	335,152 $7.2 Million
Q1 2019 May 14, 2019	SELL	$41.26 - $58.35 $2.66 Million - $3.76 Million	-64,362 Reduced 42.26%	87,949 $3.82 Million
Q4 2018 Feb 14, 2019	BUY	$44.93 - $73.38 $2.07 Million - $3.39 Million	46,165 Added 43.49%	152,311 $7.2 Million
Q3 2018 Nov 14, 2018	BUY	$56.85 - $80.35 $1.29 Million - $1.83 Million	22,748 Added 27.28%	106,146 $7.92 Million
Q2 2018 Aug 14, 2018	SELL	$35.85 - $57.05 $3.02 Million - $4.8 Million	-84,208 Reduced 50.24%	83,398 $4.6 Million
Q1 2018 May 15, 2018	BUY	$27.0 - $38.5 $862,110 - $1.23 Million	31,930 Added 23.53%	167,606 $6.38 Million
Q4 2017 Feb 14, 2018	BUY	$28.0 - $33.2 $2.12 Million - $2.51 Million	75,630 Added 125.95%	135,676 $3.8 Million
Q3 2017 Nov 14, 2017	BUY	$24.5 - $31.1 $1.47 Million - $1.87 Million	60,046	60,046 $1.86 Million

Others Institutions Holding SRDX

# of Institutions

126

Shares Held

11.7M

Call Options Held

1.4K

Put Options Held

8.6K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $533M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account